Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 6259

  • Filters activated: Field: Title/Abstract. Clear all
2.

Nocturnal ventricular arrhythmias are associated with severity of cardiovascular autonomic neuropathy in type 2 diabetes.

Chen C, Wang W, Zhou W, Jin J, Chen W, Zhu D, Bi Y.

J Diabetes. 2019 Feb 15. doi: 10.1111/1753-0407.12908. [Epub ahead of print]

PMID:
30767398
3.

Investigation of the utility of Curcuma caesia in the treatment of diabetic neuropathy.

Grover M, Shah K, Khullar G, Gupta J, Behl T.

J Pharm Pharmacol. 2019 Feb 14. doi: 10.1111/jphp.13075. [Epub ahead of print] Review.

PMID:
30767224
4.

Neurons and Microglia; A Sickly-Sweet Duo in Diabetic Pain Neuropathy.

Rajchgot T, Thomas SC, Wang JC, Ahmadi M, Balood M, Crosson T, Dias JP, Couture R, Claing A, Talbot S.

Front Neurosci. 2019 Jan 31;13:25. doi: 10.3389/fnins.2019.00025. eCollection 2019. Review.

5.

Lens autofluorescence ratio as a noninvasive marker of peripheral diabetic neuropathy.

Sertbas M, Sertbas Y, Uner OE, Elarslan S, Okuroglu N, Ak F, Dayan A, Ozdemır A.

Pol Arch Intern Med. 2019 Feb 14. doi: 10.20452/pamw.4449. [Epub ahead of print]

6.

Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus.

Ng PS, Dyck PJ, Laughlin RS, Thapa P, Pinto MV, Dyck PJB.

Neurology. 2019 Feb 13. pii: 10.1212/WNL.0000000000007020. doi: 10.1212/WNL.0000000000007020. [Epub ahead of print]

PMID:
30760636
7.

Antihypernociceptive and neuroprotective effects of Combretin A and Combretin B on streptozotocin-induced diabetic neuropathy in mice.

Mbiantcha M, Khalid R, Dawe A, Mehreen A, Atsamo DA, Ateufack G, Hamza D, Nana WY, Bomba FTD, Naeem RU, Izhar A.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Feb 13. doi: 10.1007/s00210-019-01626-1. [Epub ahead of print]

PMID:
30759263
8.

Cardiovascular autonomic neuropathy in type 2 diabetic patients.

Breder ISS, Sposito AC.

Rev Assoc Med Bras (1992). 2019 Jan;65(1):56-60. doi: 10.1590/1806-9282.65.1.56.

9.

The Correlation between Malondialdehyde and Nerve Growth Factor Serum Level with Diabetic Peripheral Neuropathy Score.

Decroli E, Manaf A, Syahbuddin S, Syafrita Y, Dillasamola D.

Open Access Maced J Med Sci. 2019 Jan 14;7(1):103-106. doi: 10.3889/oamjms.2019.029. eCollection 2019 Jan 15.

10.

Diagnosis of cardiovascular autonomic neuropathy in diabetes: as simple as possible, but not simpler?

Pafili K, Papanas N.

Acta Diabetol. 2019 Feb 8. doi: 10.1007/s00592-018-01279-1. [Epub ahead of print] No abstract available.

PMID:
30734867
11.

Diagnosis of cardiovascular autonomic neuropathy in diabetes: as simple as possible, but not simpler? An answer.

Bax G, Bellavere F.

Acta Diabetol. 2019 Feb 8. doi: 10.1007/s00592-018-01281-7. [Epub ahead of print] No abstract available.

PMID:
30734866
12.

Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes.

Hansen TM, Brock B, Juhl A, Drewes AM, Vorum H, Andersen CU, Jakobsen PE, Karmisholt J, Frøkjær JB, Brock C.

J Diabetes Complications. 2019 Jan 4. pii: S1056-8727(18)30600-7. doi: 10.1016/j.jdiacomp.2018.12.016. [Epub ahead of print]

PMID:
30733057
13.

Nanoparticle-microRNA-146a-5p polyplexes ameliorate diabetic peripheral neuropathy by modulating inflammation and apoptosis.

Luo Q, Feng Y, Xie Y, Shao Y, Wu M, Deng X, Yuan W, Chen Y, Shi X.

Nanomedicine. 2019 Feb 2. pii: S1549-9634(19)30019-X. doi: 10.1016/j.nano.2019.01.007. [Epub ahead of print]

14.

Cutaneous microangiopathy in patients with type 2 diabetes: impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy.

Sugimoto K, Murakami H, Deguchi T, Arimura A, Daimon M, Suzuki S, Shimbo T, Yagihashi S.

J Diabetes Investig. 2019 Feb 4. doi: 10.1111/jdi.13020. [Epub ahead of print]

15.

Relationship between sonographically measured median nerve cross-sectional area and presence of peripheral neuropathy in diabetic subjects.

Attah FA, Asaleye CM, Omisore AD, Kolawole BA, Aderibigbe AS, Alo M.

World J Diabetes. 2019 Jan 15;10(1):47-56. doi: 10.4239/wjd.v10.i1.47.

16.

Tricyclic Antidepressant and/or γ-Aminobutyric Acid-Analog Use Is Associated With Fall Risk in Diabetic Peripheral Neuropathy.

Randolph AC, Lin YL, Volpi E, Kuo YF.

J Am Geriatr Soc. 2019 Jan 29. doi: 10.1111/jgs.15779. [Epub ahead of print]

PMID:
30694557
17.

Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy.

Richner M, Ferreira N, Dudele A, Jensen TS, Vaegter CB, Gonçalves NP.

Front Neurosci. 2019 Jan 14;12:1038. doi: 10.3389/fnins.2018.01038. eCollection 2018. Review.

18.

3-Mercapto-5H-1,2,4-Triazino[5,6-b]Indole-5-Acetic Acid (Cemtirestat) Alleviates Symptoms of Peripheral Diabetic Neuropathy in Zucker Diabetic Fatty (ZDF) Rats: A Role of Aldose Reductase.

Soltesova Prnova M, Svik K, Bezek S, Kovacikova L, Karasu C, Stefek M.

Neurochem Res. 2019 Jan 28. doi: 10.1007/s11064-019-02736-1. [Epub ahead of print]

PMID:
30689163
19.

High resolution ultrasonography of peripheral nerves in diabetic peripheral neuropathy.

Singh Y, Dixit R, Singh S, Garg S, Chowdhury N.

Neurol India. 2019 Jan-Feb;67(Supplement):S71-S76. doi: 10.4103/0028-3886.250719.

20.

The prevalence of neuropathy among type 1 diabetic adolescents in Iran: a systematic review and meta-analysis.

Vasigh A, Abdi A, Borji M, Tarjoman A.

Int J Adolesc Med Health. 2019 Jan 26. pii: /j/ijamh.ahead-of-print/ijamh-2018-0223/ijamh-2018-0223.xml. doi: 10.1515/ijamh-2018-0223. [Epub ahead of print]

PMID:
30685741

Supplemental Content

Loading ...
Support Center